Developing the next drug for one of our global health challenges requires teams of diverse scientists with inter-disciplinary knowledge and skills. In this unit of study you will work together in teams under the supervision of expert academics and industry partners to address the unmet needs and questions of real-world projects in the pharmacological treatment of disease. You will explore ethical, societal and clinical aspects of developing and regulating new treatments for chronic diseases. You will expand your skills in evaluation of evidence from scientific, economic and industry sources. In this capstone unit you will extend your skills in critical thinking, problem-solving, project management, communicating with lay and expert audiences, cultural competence and collaboration – all highly valued by employers. This unit will foster your ability to work in interdisciplinary teams, which is essential for professional and research pathways in future. This unit of study is highly recommended for students who are interested in careers in the medical technology and pharmaceutical industry, commercialisation and start-ups, health professions (e.g. medicine, pharmacy), government policy and regulatory agencies.
Unit details and rules
Academic unit | Pharmacy |
---|---|
Credit points | 6 |
Prerequisites
?
|
{(PCOL2011 or PCOL2021 or MEDS2002) or [BMED2401 and 12cp from (BMED2402 or BMED2403 or BMED2405 or BMED2406)]} and (PCOL2012 or PCOL2022 or PCOL2922) |
Corequisites
?
|
None |
Prohibitions
?
|
None |
Assumed knowledge
?
|
None |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Kellie Charles, kellie.charles@sydney.edu.au |
---|---|
Tutor(s) | Kellie Charles, kellie.charles@sydney.edu.au |
Slade Matthews, slade.matthews@sydney.edu.au | |
Jonathon Arnold, jonathon.arnold@sydney.edu.au | |
Tina Hinton, tina.hinton@sydney.edu.au | |
Mariam Mamlouk, mariam.mamlouk@sydney.edu.au | |
Eric Sparkes, eric.sparkes@sydney.edu.au | |
Arsalan Yousuf, arsalan.yousuf@sydney.edu.au |